Author

N. Larmonier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Zouine· 1 shared B. Le Bail· 1 shared D. Chalopin· 1 shared E. Ramel· 1 shared J. Giraud· 1 shared J.-F. Blanc· 1 shared L. Chiche· 1 shared M. Nikolski· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Zouine

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

TREM1+ regulatory myeloid cells expand in steatohepatitis-HCC and associate with poor prognosis and therapeutic resistance to immune checkpoint blockade

J. Giraud, D. Chalopin, E. Ramel, T. Boyer, A. Zouine, M.-A. Derieppe, N. Larmonier, O. Adotevi, B. Le Bail, J.-F. Blanc, L. Chiche, M. Nikolski, M. Saleh

This study identifies TREM1+CD163+ regulatory myeloid cells in steatohepatitis-HCC that suppress T cell function and are linked to poor prognosis and resistance to immune checkpoint therapy.

bioRxiv · Nov 9, 2022 · PreprintImmunology